{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:05:41Z","timestamp":1740103541775,"version":"3.37.3"},"reference-count":26,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2003,1,13]],"date-time":"2003-01-13T00:00:00Z","timestamp":1042416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2003,4,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cancer gene therapy with the aid of herpes simplex virus type 1 thymidine kinase gene (HSV\u2010TK) and anti\u2010herpes drug ganciclovir (GCV) has been widely used and its efficacy has been demonstrated in a variety of different malignant cells and animal tumor models. It is also commonly accepted, however, that this gene therapy regimen needs to be enhanced for a true clinical success. We studied whether polyamine biosynthesis inhibition by 2\u2010difluoromethylornithine (DFMO), a clinically tested and well\u2010tolerated chemotherapeutic drug, can increase the cytotoxicity of HSV\u2010TK\/GCV in 9L rat glioma cells. Our initial experiments showed that polyamine depletion actually protected the cells from cytotoxicity if GCV treatment was started too early after removal of DFMO. Analyses of cell growth, intracellular polyamine pools and cell cycle phase distribution suggested that later initiation of GCV treatment would be more beneficial due to increased proportion of cells in the middle of the cell cycle S phase. When the cells were exposed to GCV 3 or 4 days after removal of DFMO from growth medium, the cytotoxicity was increased up to 2.5\u2010fold. We also verified whether cell cycle blockage <jats:italic>per se<\/jats:italic> could yield similar effect as DFMO. Our results from serum deprivation experiments showed that, despite of apparent cell growth and cell cycle phase distribution effects, serum starvation was weaker enhancer of HSV\u2010TK\/GCV cytotoxicity than DFMO. Finally, the general utility of HSV\u2010TK\/GCV + DFMO combination was tested in another tumor cell type, human prostate carcinoma cell line DU\u2010145. DFMO sensitized these cells to HSV\u2010TK\/GCV cytotoxicity, but the effect was less prominent than in 9L cells. In conclusion, we have demonstrated that a correctly timed induction of DFMO\u2010mediated polyamine biosynthesis inhibition can enhance the efficiency of HSV\u2010TK\/GCV gene therapy <jats:italic>in vitro<\/jats:italic>. The observed synergistic effect is potentially useful in clinical trials because, as opposed to use of other cell cycle\u2010altering drugs, DFMO has already been tested in the treatment of human tumors and used as chemo preventive regimen with excellent tolerability. \u00a9 2003 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ijc.10942","type":"journal-article","created":{"date-parts":[[2003,2,6]],"date-time":"2003-02-06T01:52:07Z","timestamp":1044496327000},"page":"380-388","source":"Crossref","is-referenced-by-count":1,"title":["Polyamine biosynthesis inhibition enhances HSV\u20101 thymidine kinase\/ganciclovir\u2010mediated cytotoxicity in tumor cells"],"prefix":"10.1002","volume":"104","author":[{"given":"Tiina","family":"Pasanen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Karppinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leena","family":"Alhonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juhani","family":"J\u00e4nne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarmo","family":"Wahlfors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,2,4]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"5276","article-title":"Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy","volume":"46","author":"Moolten FL","year":"1986","journal-title":"Cancer Res"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1317968"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1089\/104303400750038499"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1089\/104303400750035726"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/07853899109148056"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00000852"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(94)90109-0"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(84)90090-7"},{"key":"e_1_2_6_10_2","first-page":"4950","article-title":"Effects of dicyclohexylamine sulfate, a spermidine synthase inhibitor, in 9L rat brain tumor cells","volume":"45","author":"Feuerstein BG","year":"1985","journal-title":"Cancer Res"},{"key":"e_1_2_6_11_2","first-page":"2783","article-title":"Sensitization of 9L rat brain gliosarcoma cells to 1,3\u2010bis(2\u2010chloroethyl)\u20101\u2010nitrosourea by \u03b1\u2010difluoromethylornithine, an ornithine decarboxylase inhibitor","volume":"41","author":"Hung DT","year":"1981","journal-title":"Cancer Res"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6417790"},{"key":"e_1_2_6_13_2","first-page":"2132","article-title":"Chemosensitization of cultured human carcinoma cells to 1,3\u2010bis(2\u2010chloroethyl)\u20101\u2010nitrosourea by difluoromethylornithine\u2010induced polyamine depletion","volume":"45","author":"Seidenfeld J","year":"1985","journal-title":"Cancer Res"},{"key":"e_1_2_6_14_2","first-page":"2541","article-title":"Decreased cytotoxicity of 1\u2010\u03b2\u2010d\u2010arabinofuranosylcytosine in 9L rat brain tumor cells pretreated with \u03b1\u2010difluoromethylornithine in vitro","volume":"43","author":"Oredsson SM","year":"1983","journal-title":"Cancer Res"},{"key":"e_1_2_6_15_2","first-page":"39","article-title":"Decreased cytotoxicity of arizidinylbenzoquinone caused by polyamine depletion in 9L rat brain tumor cells in vitro","volume":"44","author":"Alhonen\u2010Hongisto L","year":"1984","journal-title":"Cancer Res"},{"key":"e_1_2_6_16_2","first-page":"4440","article-title":"Decreased cell kill of vincristine and methotrexate against 9L rat brain tumor cells in vitro caused by \u03b1\u2010difluoromethylornithine\u2010induced polyamine depletion","volume":"44","author":"Alhonen\u2010Hongisto L","year":"1984","journal-title":"Cancer Res"},{"key":"e_1_2_6_17_2","first-page":"1155","article-title":"Reduced cytocidal efficacy for adriamycin in cultured human carcinoma cells depleted of polyamines by difluoromethylornithine treatment","volume":"46","author":"Seidenfeld J","year":"1986","journal-title":"Cancer Res"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4827(81)90420-1"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2184.1996.tb00988.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2144\/98244st01","article-title":"Herpes simplex virus thymidine kinase green fluorescent protein fusion gene: new tool for gene transfer studies and gene therapy","volume":"24","author":"Loimas S","year":"1998","journal-title":"Biotechniques"},{"key":"e_1_2_6_21_2","first-page":"165","article-title":"Viral vectors carrying a marker\u2010suicide fusion gene (TK\u2010GFP) as tools for TK\/GCV\u2010mediated cancer gene therapy","volume":"5","author":"Loimas S","year":"2000","journal-title":"Gene Ther Mol Biol"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700286"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(92)80093-6"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1089\/15204559950020067"},{"key":"e_1_2_6_25_2","first-page":"47","article-title":"Altered cell cycle phase distributions in cultured human carcinoma cells partially depleted of polyamines by treatment with difluoromethylornithine","volume":"46","author":"Seidenfeld J","year":"1986","journal-title":"Cancer Res"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.15.1122"},{"key":"e_1_2_6_27_2","first-page":"657","article-title":"Phase I chemoprevention study of difluoromethylornithine in subjects with organ transplants","volume":"10","author":"Carbone PP","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.10942","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.10942","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T12:23:44Z","timestamp":1697459024000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.10942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,4]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,4,10]]}},"alternative-id":["10.1002\/ijc.10942"],"URL":"https:\/\/doi.org\/10.1002\/ijc.10942","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"type":"print","value":"0020-7136"},{"type":"electronic","value":"1097-0215"}],"subject":[],"published":{"date-parts":[[2003,2,4]]}}}